Overview

Dose Escalation of Different Concentrations of ZK 245186 in Atopic Dermatitis

Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and efficacy of three concentrations of ZK 245186 ointment and vehicle on increasing body surface areas for the treatment of atopic dermatitis and to obtain dose-response information for the three concentrations.
Phase:
Phase 2
Details
Lead Sponsor:
Bayer